Literature DB >> 19387873

Hemangiopericytoma-associated hypoglycemia improved by glucocorticoid therapy: a case report.

Inan Anaforoğlu1, Alimdar Simşek, Turhan Turan, Ekrem Algün.   

Abstract

A 59-year-old man was admitted because of recurrent, severe hypoglycemia. He had multiple metastases from a meningeal hemangiopericytoma, which had been operated on 12 years earlier. The results of laboratory testing at the time of hypoglycemia showed very low serum levels of insulin, C-peptide, and growth hormone, with slightly high levels of insulin-like growth factor-II, and a normal level of insulin-like growth factor-I. The diagnosis of hemangiopericytoma-associated hypoglycemia was proposed. The patient was given corticosteroid therapy, which ameliorated symptoms of hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19387873     DOI: 10.1007/s12020-009-9197-8

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  10 in total

1.  Retroperitoneal hemangiopericytoma associated with hypoglycemia and masculinization.

Authors:  J W HOWARD; P L DAVIS
Journal:  Del Med J       Date:  1959-02

2.  HEMANGIOPERICYTOMA: A VASCULAR TUMOR FEATURING ZIMMERMANN'S PERICYTES.

Authors:  A P Stout; M R Murray
Journal:  Ann Surg       Date:  1942-07       Impact factor: 12.969

3.  The expression and role of insulin-like growth factor II in malignant hemangiopericytomas.

Authors:  K Pavelić; S Spaventi; V Gluncić; A Matejcić; D Pavicić; N Karapandza; Z Kusić; J Lukac; C Dohoczky; T Cabrijan; J Pavelić
Journal:  J Mol Med (Berl)       Date:  1999-12       Impact factor: 4.599

4.  Hypoglycemic disorders.

Authors:  F J Service
Journal:  N Engl J Med       Date:  1995-04-27       Impact factor: 91.245

5.  Abnormal serum IGF-II transport in non-islet cell tumor hypoglycemia results from abnormalities of both IGF binding protein-3 and acid labile subunit and leads to elevation of serum free IGF-II.

Authors:  W H Daughaday; B Trivedi; R C Baxter
Journal:  Endocrine       Date:  1995-06       Impact factor: 3.633

Review 6.  Hypoglycemia.

Authors:  Jean-Marc Guettier; Phillip Gorden
Journal:  Endocrinol Metab Clin North Am       Date:  2006-12       Impact factor: 4.741

7.  Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia.

Authors:  Izumi Fukuda; Naomi Hizuka; Yukiko Ishikawa; Kumiko Yasumoto; Yuko Murakami; Akira Sata; Junko Morita; Makiko Kurimoto; Yumiko Okubo; Kazue Takano
Journal:  Growth Horm IGF Res       Date:  2006-07-24       Impact factor: 2.372

8.  Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia.

Authors:  N Hizuka; I Fukuda; K Takano; Y Okubo; K Asakawa-Yasumoto; H Demura
Journal:  Endocr J       Date:  1998-04       Impact factor: 2.349

Review 9.  Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases.

Authors:  Jan Willem B de Groot; Bart Rikhof; Jaap van Doorn; Henk J G Bilo; Maarten A Alleman; Aafke H Honkoop; Winette T A van der Graaf
Journal:  Endocr Relat Cancer       Date:  2007-12       Impact factor: 5.678

10.  The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia.

Authors:  J D Teale; G Wark
Journal:  Clin Endocrinol (Oxf)       Date:  2004-04       Impact factor: 3.478

  10 in total
  3 in total

1.  Recurrent meningeal hemangiopericytoma with multiple metastasis and hypoglycemia: a case report.

Authors:  Jammy Kin Iong Chan; Wah Cheuk; Luen Cheong Ho; Jian-Ming Wen
Journal:  Case Rep Med       Date:  2012-09-16

2.  Solitary fibrous tumors and so-called hemangiopericytoma.

Authors:  Nicolas Penel; Eric Yaovi Amela; Gauthier Decanter; Yves-Marie Robin; Perrine Marec-Berard
Journal:  Sarcoma       Date:  2012-04-08

3.  Hypoglycemia mediated by paraneoplastic production of Insulin like growth factor-2 from a malignant renal solitary fibrous tumor - clinical case and literature review.

Authors:  Ameer Khowaja; Brianna Johnson-Rabbett; John Bantle; Amir Moheet
Journal:  BMC Endocr Disord       Date:  2014-06-17       Impact factor: 2.763

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.